William Rose serves as Executive at REATA PHARMACEUTICALS INC, where they oversee executive responsibilities. Since joining the company, William Rose has executed 11 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Sep 26, 2023 involved selling 180,909 shares valued at $0.
William Rose currently holds 379,281 shares of REATA PHARMACEUTICALS INC (RETA), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, William Rose has been a net neutral trader of RETA stock. They have purchased $0 and sold $0 worth of shares.
William Rose's most recent insider trade was on Sep 26, 2023, when they sold 180,909 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Sep 26, 2023 | RETA | $0 | Disposition | 45 | $N/A | Discretionary |
| Sep 26, 2023 | RETA | $0 | Disposition | 20 | $N/A | Discretionary |
| Sep 26, 2023 | RETA | $0 | Disposition | 7,886 | $N/A | Discretionary |
| Sep 26, 2023 | RETA | $0 | Disposition | 19,795 | $N/A | Discretionary |
| Sep 26, 2023 | RETA | $0 | Disposition | 11,618 | $N/A | Discretionary |
| Sep 26, 2023 | RETA | $0 | Disposition | 379,281 | $N/A | Discretionary |
| Aug 23, 2023 | RETA | $0 | Gift | 500,000 | $N/A | Discretionary |
| Dec 7, 2017 | RETA | $0 | Will Acquisition | 67,735 | $N/A | Discretionary |
| Dec 7, 2017 | RETA | $0 | Will Acquisition | 67,735 | $N/A | Discretionary |